Navigation Links
Fibromyalgia Is Not All In Your Head, New Research Confirms
Date:6/20/2013

RENSSELAER, N.Y., June 20, 2013 /PRNewswire/ -- Fibromyalgia, a painful condition affecting approximately 10 million people in the U.S., is not imaginary after all, as some doctors have believed.  A discovery, published this month in PAIN MEDICINE (the journal of the American Academy of Pain Medicine) at http://www.ncbi.nlm.nih.gov/pubmed/23691965, shows that fibromyalgia may have a rational biological basis located in the skin.

(Photo: http://photos.prnewswire.com/prnh/20130620/NY35196 )

Characterized by subjective complaints of widespread deep tissue pain, tenderness in the hands and feet, fatigue, sleep disorders, and cognitive decline, the disorder was widely considered as psychosomatic ("imagined in the head"). Imaging techniques have recently revealed increased brain activity in pain centers, but the source for this hyperactivity activity is unknown.

Now, a breakthrough discovery by scientists at Integrated Tissue Dynamics LLC (Intidyn) has provided a biological rationale for this enigmatic disease. The company, founded by neuroscientists Dr. Frank L. Rice and Dr. Phillip J. Albrecht, utilized a unique multi-molecular ChemoMorphometric Analysis (CMA) to evaluate nerve fibers within small skin biopsies. The study was limited to women who are more than twice as likely to be afflicted by fibromyalgia as men.

"We detected extremely excessive sensory nerve fibers around blood vessels in the palms of the hands," said Dr. Rice. "This discovery provides concrete evidence of a fibromyalgia-specific pathology that is clearly outside of the brain.  This could be used to facilitate the diagnosis of the disease and provide a new target for the development of truly effective therapeutics."

Performed in collaboration with Albany Medical Center neurologists Dr. Charles E. Argoff and Dr. James Wymer and Dr. James Storey of Upstate Clinical Research Associates (Albany, NY), the study was funded by Forest Laboratories and Eli Lilly.  Both pharmaceutical companies have developed FDA-approved medications with similar functions (Serotonin/Norepinephrine Reuptake Inhibitors, SNRI) that provide at least some degree of relief for many fibromyalgia patients.

"Knowing how these drugs were supposed to work on molecules in the brain," Dr. Albrecht added, "we had evidence that similar molecules were involved in the function of nerve endings on the blood vessels. Therefore, we hypothesized that fibromyalgia might involve a pathology in that location." As the results demonstrate, they were correct.

A Thermostat for the Skin

Importantly, the excessive nerve fibers were concentrated around tiny muscular valves, called arteriole-venule (AV) shunts (see diagram).  In humans, these shunts are found in the palms of our hands and soles of our feet and work like the radiator in a car. In warm conditions, the shunts close, which forces blood into the capillaries at the skin surface to radiate heat from the body. Under cold conditions, the shunts open allowing blood to bypass the capillaries to conserve heat, which is why our hands get cold.

According to Dr. Albrecht, "the excess sensory innervation may explain why fibromyalgia patients typically have especially tender and painful hands."

Noting that blood flow to the hands is normally known to be diverted to muscles during exercise, Dr. Rice proposes that "That mismanaged blood flow due to malfunctioning shunts could also interfere with blood flow to the muscles throughout the body. This could be the source of wide spread muscular pain, achiness and fatigue which are thought to be due to a build-up of lactic acid and low levels of inflammation fibromyalgia patients. This, in turn, could contribute to the hyperactivity in the brain."

A description of this study for the general public can be found at: http://www.intidyn.com/Newsroom/article-0008.html

CONTACT: Frank L. Rice, PhD
frankrice@intidyn.com
866-610-7581, ext. 102

 


'/>"/>
SOURCE Intidyn
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
2. Soterix Medical Inc. reports positive results from High-Definition tDCS Fibromyalgia Trial at Harvard Medical School
3. WAISMANN METHOD® Medical Director Voices Support for Fibromyalgia Awareness Day
4. With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation
5. BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
6. New BD Biosciences Flow Cytometry Cell Analyzer Enables Complex Multicolor Experiments in Disease Research
7. Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics
8. Southern Research Institute Names Arthur J. Tipton, Ph.D. President and CEO
9. University Researchers Use Biozoom Scanner To Investigate Relationship Between Stress And Work
10. Pancreatic Cancer Advocates Call on Congress to Protect Medical Research Funding From Sequestration Cuts
11. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2017)...  Life Flight Network and PeaceHealth Oregon Network announced they ... and operational efficiency for patients at hospitals in ... Cottage Grove , and Florence, Oregon ... Flight Network work collaboratively to move patients who require the ... time sensitive emergency exists. ...
(Date:7/31/2017)... Pharmacy, Inc. (NYSE: DPLO), has been named one of the ... Crain,s Detroit Business . The annual Crain,s Fast ... growth. This year,s edition measures growth from 2013 to 2016. ... list, visit crainsdetroit.com/awards/fast_50/2017 .  "Being named ... Phil Hagerman , CEO and chairman of Diplomat. "We,ve made ...
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
Breaking Medicine Technology:
(Date:8/21/2017)... ... August 21, 2017 , ... Duncan Insurance Agency debuts the ... of Michigan. The new initiative fundraises for the Kalamazoo Humane Society (KHS), which ... animal protection and welfare by addressing the root causes of pet overpopulation. As ...
(Date:8/21/2017)... ... August 21, 2017 , ... San Diego physician and surgeon Dr. James Veltmeyer, ... announced his candidacy for the 52nd Congressional District currently held by Representative Scott Peters. ... to this country at age eleven after suffering homelessness and hardship in a distant ...
(Date:8/20/2017)... ... August 20, 2017 , ... HIPAA ... Management System has assisted multiple clients in successfully passing audits such as ... Control Level 2 (AICPA SOC Level 2), and State Data Use Agreement Audits. ...
(Date:8/19/2017)... (PRWEB) , ... August 18, 2017 , ... Western University ... health and education to launch the University’s new Center for Innovation on Wednesday, September ... Health Education Center Lecture Hall 1, followed by a technology exhibition from 1 to ...
(Date:8/19/2017)... ... August 19, 2017 , ... Curl Keeper® is excited ... The Curl Leaders, Editors’ Choice 2017 Award for the second year in a row. ... stylists and curlies alike was voted Best Moisturizer for Type 2 Wavies and Best ...
Breaking Medicine News(10 mins):